We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current HLVX market cap is 102.79M. The company's latest EPS is USD -2.9371 and P/E is -0.71.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -49.8M | -34.73M | -26.38M | -27.79M | -7.6M |
| Net Income | -46.83M | -40.67M | -25.82M | -33.95M | -6.06M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -53.43M | -65.11M | -133.35M | -138.69M |
| Net Income | -102.41M | -159.81M | -123.57M | -147.27M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 314.18M | 276.93M | 220.62M | 192.69M | 178.82M |
| Total Liabilities | 75.27M | 72M | 36.35M | 38.2M | 27.91M |
| Total Equity | 238.91M | 204.93M | 184.27M | 154.49M | 150.91M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 127.16M | 317.21M | 344.43M | 192.69M |
| Total Liabilities | 227.92M | 49.98M | 78.91M | 38.2M |
| Total Equity | -100.76M | 267.23M | 265.53M | 154.49M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -33M | -62.78M | -90.6M | -108.79M | -12.72M |
| Investing | -57.66M | -61.13M | -10.49M | 58.4M | -94.26M |
| Financing | 15.06M | 15.68M | -11.82M | -11.82M | N/A |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.27M | -61.99M | -86.78M | -108.79M |
| Investing | N/A | -6.51M | -94.64M | 58.4M |
| Financing | 1.33M | 224.97M | 118.7M | -11.82M |
| Market Cap | 102.79M |
| Price to Earnings Ratio | -0.71 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.68 |
| Price to Book Ratio | 0.68 |
| Dividend Yield | - |
| Shares Outstanding | 50.14M |
| Average Volume (1 week) | 107.06k |
| Average Volume (1 Month) | 466.31k |
| 52 Week Change | 24.24% |
| 52 Week High | 2.15 |
| 52 Week Low | 1.34 |
| Spread (Intraday) | 0.2 (9.35%) |
| Company Name | HilleVax Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.hillevax.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
